Holy Name Medical Center announced a new partnership with a national organization founded in Teaneck supporting Jewish women and their families at high risk for, or diagnosed with, breast or ovarian cancer.
“Holy Name’s partnership with Sharsheret will enhance the education, support and amenities provided to Jewish women facing breast and ovarian cancer in ways that go far beyond traditional health care,” said Michael Maron, CEO and president of Holy Name. “Founded in Teaneck, Sharsheret has a dynamic support network in the North Jersey community and an outstanding national reputation of supporting Jewish women facing breast and ovarian cancer. This new partnership is a natural fit for us, as we continue to provide high-quality, culturally relevant health care to the many diverse patient groups in our community.”
Holy Name has been focused on culturally sensitive care for a variety of communities including Jewish, Asian and Hispanic populations.
“Working together with Holy Name Medical Center, we understand firsthand the importance of providing the highest level of care while being intimately knowledgeable about the unique issues and concerns of each and every patient,” said Sharsheret Executive Director Elana Silber. “Our partnership serves as a model of true patient-centered care, support and education that will improve the quality of life for thousands of local Jewish women and families facing breast and ovarian cancer.”
The new partnership provides women (whether or not they are Jewish) and their families better understanding choices for treatment, and allows women living with metastatic or advanced breast and ovarian cancer to received specialized support.
